How modern trial designs propel cancer therapies to the market - interview
Clinical trials are becoming increasingly complex as emerging technologies such as immunotherapy enter the mainstream.
Archives for September 12, 2024
How early utilisation of AI can de-risk and accelerate clinical development
Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) potential to transform drug development.
Innovative approaches to opioid use disorder treatment
As local and state governments in the US begin to receive and distribute their opioid settlement funds, Sonara Health has developed a comprehensive report analyzing how over $50 billion in national funds can be effectively allocated to address the opioid...
The intersection of ethics and AI in healthtech marketing: Insights from ObvioHealth
In the crowded landscape of health tech, ethical marketing has emerged as a crucial differentiator for companies striving to stand out.